Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Alfred Sandrock | President and CEO | 2024-04-02 | 12,115 | $9.86 | $119.45kSell |
Robin Swartz | Chief Operating Officer | 2024-04-02 | 1,357 | $9.88 | $13.41kSell |
Todd Alfred Carter | Chief Scientific Officer | 2024-02-21 | 3,365 | $7.47 | $25.14kSell |
Peter P. Pfreundschuh | Chief Financial Officer | 2024-02-21 | 3,764 | $7.46 | $28.08kSell |
Alfred Sandrock | President and CEO | 2024-02-21 | 13,033 | $7.46 | $97.23kSell |
Robin Swartz | Chief Operating Officer | 2024-02-21 | 3,966 | $7.45 | $29.55kSell |
Todd Alfred Carter | Chief Scientific Officer | 2024-02-20 | 602 | $7.68 | $4.62kSell |
Todd Alfred Carter | Chief Scientific Officer | 2024-01-17 | 1,266 | $7.18 | $9.09kSell |
Robin Swartz | Chief Operating Officer | 2024-01-17 | 2,543 | $7.15 | $18.18kSell |
Peter P. Pfreundschuh | Chief Financial Officer | 2023-10-03 | 13,567 | $6.99 | $94.83kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Neurocrine Biosciences Inc | 15.77% | 8,575,316 | $72.03M | Insider |
Ecor1 Capital LLC | 14.94% | 8,128,014 | $68.28M | Insider |
Mark J. Levin | 11.82% | 6,427,874 | $53.99M | Insider |
Armistice Capital LLC | 8.59% | 4,672,000 | $39.24M | Institution |
Blackrock Inc | 8.08% | 4,397,444 | $36.94M | Institution |
Ecor1 Capital LLC | 7.20% | 3,917,546 | $32.91M | Institution |
Vanguard Group Inc | 5.94% | 3,231,698 | $27.15M | Institution |
Sanofi | 4.56% | 2,477,941 | $20.81M | Insider |
Farallon Capital Management LLC | 4.21% | 2,292,000 | $19.25M | Institution |
State Street Corp | 3.22% | 1,749,168 | $14.69M | Institution |